JPM
JPMorgan Chase & Co.
JPM has the edge over OZK overall, supported by stronger fundamentals and stronger modeled upside.
OZK
Bank OZK
OZK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
OZK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OZK's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OZK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
OZK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $44.10 | -13% |
| Current | 8.3x | $50.45 | — |
| Fair | 8.4x | $50.57 | +0.2% |
| Forward | 8.4x | $50.45 | — |
| Expensive | 11x | $67.55 | +34% |
Historical ranges are pointers, not guarantees.
OZK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over OZK on the outlook, with more favorable earnings and revenue expectations.
OZK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect OZK's profitability to weaken, with its earnings and revenue holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over OZK on earnings, with more consistent year-over-year improvement.
OZK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.01 | -0.7% |
| Q2 2026 | $6.05 | -1.8% |
| Q1 2026 | $6.14 | +0.7% |
| Q4 2025 | $6.17 | +0.5% |
| Q3 2025 | $6.20 | +2% |
| Q2 2025 | $6.16 | +2.3% |
| Q1 2025 | $6.10 | +2.2% |
| Q4 2024 | $6.14 | +4.6% |
| Q3 2024 | $6.08 | +6.5% |
OZK earned $6.05 per share over the past year, down 1.8% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over OZK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over OZK on profitability, with a higher operating margin.
OZK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $672.9M | -3.8% |
| Q1 2026 | $661.5M | -1.3% |
| Q4 2025 | $704.6M | +1.3% |
| Q3 2025 | $731.1M | +2.2% |
| Q2 2025 | $699.6M | +0.4% |
| Q1 2025 | $670.5M | +0.6% |
| Q4 2024 | $695.6M | +7% |
| Q3 2024 | $715.7M | +21% |
OZK's revenue grew through 2024 and has held roughly level since: $673M last quarter, down 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 32% | -2.5 points |
| Q1 2026 | 32% | -1.4 points |
| Q4 2025 | 32% | -1.4 points |
| Q3 2025 | 33% | +0.1 points |
| Q2 2025 | 34% | +1.2 points |
| Q1 2025 | 33% | -1.1 points |
| Q4 2024 | 34% | +0.2 points |
| Q3 2024 | 33% | -4.2 points |
OZK's operating margin was 32% last quarter, down 2.5 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
OZK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $189M | +48% |
| Q1 2026 | $212.1M | -12% |
| Q4 2025 | $175.3M | +45% |
| Q3 2025 | $186M | -28% |
| Q2 2025 | $128.1M | -5.4% |
| Q1 2025 | $242.3M | +8% |
| Q4 2024 | $121M | -35% |
| Q3 2024 | $258M | -3.3% |
OZK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
OZK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.2M shares |
| 1 year | -3.6% | -4.1M shares |
| 3 years | -4% | -4.6M shares |
| 5 years | -16% | -20.6M shares |
| Available history | -15% | -19.3M shares |
OZK has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $15.5M |
| Q1 2026 | $60M |
| Q4 2025 | $93.7M |
| Q3 2025 | — |
| Q2 2025 | $50.8M |
| Q1 2025 | $7.1M |
| Q4 2024 | — |
| Q3 2024 | $462,000 |
OZK spent $169M buying back its own shares over the past year, up 190% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
OZK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
OZK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
OZK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 75.3 | Neutral |
OZK's weekly RSI is 54 (neutral) and its Stochastic is 75 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
OZK PE vs Financial Services Sector
| Metric | OZK | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 36% below |
| PE % | 49 | 63 | 14 pts below |
OZK has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
OZK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.3 | 4.4% above |
| 20 week MA | $49.5 | 1.8% above |
| 50 week MA | $48.5 | 4% above |
| 100 week MA | $47.8 | 5.6% above |
| 200 week MA | $44.9 | 12% above |
OZK has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
OZK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.8 | $31.1 | +1% |
| 2021 | $31.1 | $45.4 | +46% |
| 2022 | $45.4 | $40.3 | -11% |
| 2023 | $40.3 | $49.8 | +24% |
| 2024 | $49.8 | $44.6 | -11% |
| 2025 | $44.6 | $47.2 | +5.8% |
| 2026 YTD | $47.2 | $50.5 | +7% |
OZK has the edge over JPM on returns for 2026, with the stronger performance.